Healthcare Nov 26, 2021 09:41 AM (GMT+8)
Longhui medical announced that it had completed nearly 100 million yuan of round B financing on November 24. This round of financing is jointly led by Shanlan capital and Sinopharm capital, followed by Shanghai Free Trade Zone fund, and Shujian capital serves as the exclusive financial adviser. Longhui medical is an independent innovation enterprise rooted in Zhangjiang Science City. Longhui surgical robot with independent intellectual property rights is used to realize the accuracy and standardization of difficult orthopaedic surgery such as joint replacement surgery. This round of financing will be mainly used for new product development, team expansion and clinical promotion.
This text is a result of machine translation.